Description
产品说明
| 所属分类 | 微生物 > 模式菌株 |
|---|---|
| 品牌 / 来源 | CS-BIC | 中科生信 |
| 应用 | 科研，生产，主要用于生产卡霉素衍生物马格霉素衍生物，产生右旋糖酶，产生亮霉素衍生物，生产尼达霉素衍生物，产生拟青霉毒素，产生类固醇 |
| 培养基 | ATCC® Medium 312: Czapek's agar ATCC® Medium 325: Malt extract agar (Blakeslee's formula) ATCC® Medium 336: Potato dextrose agar (PDA) |
| 存储人 | NRRL |
| 出品公司 | ATCC |
| 分离来源 | 纽约州伊萨卡土壤 |
| 参考文献 | Theriault RJ. Mycarosyl macrolide antibiotics. US Patent 3,784,447 dated Jan 8 1974 Thom C. Cultural studies of species of Penicillium. U.S. Dep. Agric. Bur. Anim. Ind. 118: 1-109, 1910. Walker GJ, Pulkownik A. Action of alpha-1,6,-glucan glucohydrolase on oligosaccharides derived from dextran. Carbohydr. Res. 36: 53-66, 1974. PubMed: 4369744 Carlstrom K. Side chain degradation and 20-(alpha+beta)-reduction of progesterone by cell free preparations of Penicillium lilacinum NRRL 895. Acta Chem. Scand. Ser. B Org. Chem. Biochem. 26: 1718-1720, 1972. Carlstrom K. Transformations of steroids by cell free preparations of Penicillium lilacinum NRRL 895. IV. Enzyme catalyzed acyl transfer. Acta Chem. Scand. 28: 23-28, 1974. Lee JM, Fox PF. Purification and characterization of Paecilomyces lilacinus dextranase. Enzyme Microb. Technol. 7: 573-577, 1985. Mikami Y, et al. Paecilotoxin production in clinical or terrestrial isolates of Paecilomyces lilacinus strains. Mycopathologia 108: 195-199, 1989. PubMed: 2615806 Luangsa-Ard J, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett 321: 141-149, 2011. PubMed: 21631575 |
| 模式菌株 | 是 |
| 生长条件 | 24-26 ℃, 有氧 |
| 菌株特点 | ATCC 10114是紫色拟青霉Purpureocillium lilacinum 。 |
| 菌株类型 | 紫色拟青霉Purpureocillium lilacinum |
| 菌种又名 | NRRL 895 [8, ATCC 1123, CBS 284.36, DSM 846, IMI 27830, QM 7592] |
| 菌种名称 | ATCC10114, ATCC 10114 |
| 产品目录号 | 10114 |
| 生物安全等级 | 1 |
| 其他保藏库编号 | BCRC31616,ATCC 10114 ;ATCC 1123 ;CBS 284.36 ;DSM 846 ;IMI 27830 ;NRRL 895 ;QM 7592 |
| ATCC10114标准菌株基本信息 | ATCC ATCC10114, ATCC 10114 NRRL 895 [8, ATCC 1123, CBS 284.36, DSM 846, IMI 27830, QM 7592] 紫色拟青霉Purpureocillium lilacinum NRRL 纽约州伊萨卡土壤 10114 BCRC31616,ATCC 10114 ;ATCC 1123 ;CBS 284.36 ;DSM 846 ;IMI 27830 ;NRRL 895 ;QM 7592 ATCC® Medium 312: Czapek's agar ATCC® Medium 325: Malt extract agar (Blakeslee's formula) ATCC® Medium 336: Potato dextrose agar (PDA) 24-26 ℃, 有氧 1 是 科研，生产，主要用于生产卡霉素衍生物马格霉素衍生物，产生右旋糖酶，产生亮霉素衍生物，生产尼达霉素衍生物，产生拟青霉毒素，产生类固醇 ATCC 10114是紫色拟青霉Purpureocillium lilacinum 。 Theriault RJ. Mycarosyl macrolide antibiotics. US Patent 3,784,447 dated Jan 8 1974 Thom C. Cultural studies of species of Penicillium. U.S. Dep. Agric. Bur. Anim. Ind. 118: 1-109, 1910. Walker GJ, Pulkownik A. Action of alpha-1,6,-glucan glucohydrolase on oligosaccharides derived from dextran. Carbohydr. Res. 36: 53-66, 1974. PubMed: 4369744 Carlstrom K. Side chain degradation and 20-(alpha+beta)-reduction of progesterone by cell free preparations of Penicillium lilacinum NRRL 895. Acta Chem. Scand. Ser. B Org. Chem. Biochem. 26: 1718-1720, 1972. Carlstrom K. Transformations of steroids by cell free preparations of Penicillium lilacinum NRRL 895. IV. Enzyme catalyzed acyl transfer. Acta Chem. Scand. 28: 23-28, 1974. Lee JM, Fox PF. Purification and characterization of Paecilomyces lilacinus dextranase. Enzyme Microb. Technol. 7: 573-577, 1985. Mikami Y, et al. Paecilotoxin production in clinical or terrestrial isolates of Paecilomyces lilacinus strains. Mycopathologia 108: 195-199, 1989. PubMed: 2615806 Luangsa-Ard J, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett 321: 141-149, 2011. PubMed: 21631575 |
Related
